Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New, Fast, Portable Saliva Screening Test Uses Infrared Light Technology to Confirm SARS-CoV-2 Infection

By LabMedica International staff writers
Posted on 31 May 2021
International research has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

The new diagnostic approach involving the use of a portable infrared instrument to detect the SARS-CoV-2 virus in saliva, was led by scientists at Monash University (Melbourne, Australia) and the Peter Doherty Institute for Infection and Immunity (Melbourne, Australia) and could pave the way for safer and more efficient COVID-19 testing.

The team identified a signature of the infectious agent in the infrared spectra of saliva from 27 out of the 29 SARS-CoV-2-infected human subjects with COVID-19-like symptoms. More...
The scientists say this is very encouraging preliminary research and are keen to see further testing with a larger patient cohort to better understand the specificity of this approach. A portable infrared spectrometer was modified to enable high throughput screening enabling the samples to be rapidly scanned in a contactless mode without having to clean the instrument between measurements.

The researchers estimate that this technique could be capable of screening 5000 samples per day per instrument, with results for each sample being ready in five minutes. Because the infrared light interacted with the vibrations of molecules, it could be used to generate a spectrum that represented a unique chemical fingerprint of the sample that was then processed using machine learning algorithms. The proposed new test also avoids the discomfort associated with nasopharyngeal swabs, an advantage that could improve community participation in testing.

A similar infrared technique known as Attenuated Total Reflectance (ATR) spectroscopy has previously been used by the Monash researchers to detect malaria and hepatitis. The new transflection infrared based approach offers triple the absorbance and hence interrogates more saliva to detect pathogens compared to the traditional ATR technology. The speed and versatility of the technique potentiates its use for point-of-care screening at airports, sporting venues, universities or schools, to triage patients for RT-PCR testing.

“The most significant advantages of using this infrared-based technology on saliva samples, include the speed and ease with which the test can be performed, its affordability and the reduced risk to both patients and healthcare workers,” said Professor Bayden Wood from the Monash University School of Chemistry.

“The approach has significant advantages over the standard Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) that is the current gold standard for detection,” said Professor Dale Godfrey from the Doherty Institute. “As we know, this requires that samples are sent to a dedicated laboratory and results take a day or more”.

“A person can contribute the sample by simply dribbling into a sterile container,” said Professor Damian Purcell from the Doherty Institute. “The result can be derived in less than five minutes and a rapid result minimizes the delay in determining if quarantine is required, therefore minimizing the risk of further spread of infection.”

Related Links:
Monash University
Peter Doherty Institute for Infection and Immunity



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.